Where does Medi&Gene Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medi&Gene Inc. ranks #20,066 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medi&Gene Inc. hold?

Medi&Gene Inc. holds 14 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is Medi&Gene Inc.'s Innovation Score?

Medi&Gene Inc. has an Innovation Score of 35.0 out of 100 (49th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medi&Gene Inc. focus on?

Medi&Gene Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 14 patents, ranking #1,619 of 7,163 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Medi&Gene Inc.'s patent grant rate increasing or decreasing?

Medi&Gene Inc.'s recent grant velocity is -82% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Medi&Gene Inc.'s patents?

Medi&Gene Inc.'s patents average 19.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medi&Gene Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medi&Gene Inc.

USPTO PatentsView assignee record - 14 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medi&gene ranks #20,066 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 11 technology areas.

#20,066
of 49,997 US assignees by volume: 49th percentile
by Innovation Score (35.0/100): 19.5
avg claims per patent: -82%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20066 · Foreign Corporation #20,066 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #20,066/49,997
PHOTO-FINISH Mashgin
CPC-FOCUS A61K · 11 areas
INNOV-THIN 35.0/100
CLAIMS-RICH 19.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -82% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mashgin Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medi&gene’s 35.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (27%) Velocity 2.2 pts (6%) Breadth 11.7 pts (33%) Claim depth 11.7 pts (33%)

Qualcomm Incorporated · highest

85
Medi&Gene · this assignee

35
3D Lighting… · lowest

7

What this shows Medi&gene's Innovation Score is 35.0/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medi&gene?

Each dot is one of Medi&gene’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medi&gene’s own 19.5 claims/patent is ABOVE the 14.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medi&gene vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medi&gene's grants concentrate

Medi&Gene Inc. is a focused PatentsView assignee: 11 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2020. By volume, Medi&gene sits between Mashgin Inc. and MemVerge, Inc..

Medi&gene's three-year grant acceleration

Medi&Gene Inc. shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mashgin

14
Masterspas

14
Mathers Hydraulic…

14
Medi Manufacturing

14
Medical & Biologi…

14
Medipixel

14
Meinan Machinery…

14
Memverge

14
Medi&Gene ◀

14

What this shows Medi&Gene holds 14 patents at rank #20,084, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medi&Gene

By rank, the assignees closest to #20,084 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Medi&Gene's primary technology class.

Medi&gene's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 49th percentile higher than 49% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Medi&Gene Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	14.3%
2016	4	28.6%
2017	3	21.4%
2019	2	14.3%
2020	1	7.1%
2022	1	7.1%
2025partial year	1	7.1%

Which technologies does Medi&Gene Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 14

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 13

C07K - Peptides 8

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

C07D - Heterocyclic Compounds 1

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medi&Gene Inc.'s patent record in context - here's where to go next.

Medi&Gene Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #20,066 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medi&Gene Inc. against Mashgin Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.